Viral Vectors
Product Description
3PBIOVIAN
-
ES -
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
3PBIOVIAN
-
ES
-
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from 3PBIOVIAN (4)
3PBIOVIAN resources (2)
-
News Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine
Rokote Laboratories Finland Ltd. has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2 (SARS-CoV-2).
-
Brochure 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pa
Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organizations (CDMOs), announced their combination.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance